These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37222860)

  • 21. Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations.
    Moloney PB; Costello DJ
    Seizure; 2021 Jan; 84():60-65. PubMed ID: 33285361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute?
    Janmohamed M; Lawn N; Spilsbury K; Chan J; Dunne J
    Epilepsia; 2021 Jan; 62(1):228-237. PubMed ID: 33236785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical factors associated with late seizure remission after failed epilepsy surgery.
    Kaye LC; Poolos ZA; Miller JW; Poolos NP
    Epilepsy Behav; 2023 Jan; 138():109055. PubMed ID: 36543042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiating antiepilepsy treatment: An update of expert consensus in Spain.
    Villanueva V; Sánchez-Álvarez JC; Carreño M; Salas-Puig J; Caballero-Martínez F; Gil-Nagel A
    Epilepsy Behav; 2021 Jan; 114(Pt A):107540. PubMed ID: 33243687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.
    Hersi H; Saarinen JT; Raitanen J; Peltola J
    Front Neurol; 2022; 13():1042168. PubMed ID: 36438960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE).
    Roberti R; Casarella A; Iudice A; La Neve A; Beghi E; Capovilla G; Di Bonaventura C; Giorgi FS; Grosso S; Iannone LF; Romigi A; Specchio LM; Zaccara G; Mecarelli O; Russo E;
    Epilepsy Behav; 2021 Mar; 116():107804. PubMed ID: 33581599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
    Odi R; Franco V; Perucca E; Bialer M
    Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brand-to-generic oxcarbazepine switch - A prospective observational study.
    Bosak M; Słowik A; Dziedzic T
    Epilepsy Res; 2019 Mar; 151():75-77. PubMed ID: 30836239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
    Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
    Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of generic versus brand-name antiepileptic medications.
    Gagne JJ; Kesselheim AS; Choudhry NK; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
    Epilepsy Behav; 2015 Nov; 52(Pt A):14-8. PubMed ID: 26386779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seizure exacerbation with anti-seizure medications in adult patients with epilepsy.
    Jaramillo MA; Pham T; Kamrudin S; Khanna R; Maheshwari A
    Epilepsy Res; 2022 Mar; 181():106885. PubMed ID: 35202904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Therapeutic Equivalence of Generic and Original Levetiracetam in Patients with Epilepsy: A Retrospective Study.
    Tharavichitkun J; Yadee T; Angkaow P; Suansanae T
    Neurol Int; 2022 Mar; 14(1):271-283. PubMed ID: 35324578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching between phenytoin generics in patients with epilepsy may lead to increased risk of breakthrough seizure: chart analysis and practice recommendations.
    Shin JW; Chu K; Jung KH; Lee ST; Moon J; Lee SK
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1017-22. PubMed ID: 25295717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
    Margolese HC; Wolf Y; Desmarais JE; Beauclair L
    Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic substitution of anti-epileptic drugs. A needed battle?
    Al-Baradie RS
    Neurosciences (Riyadh); 2008 Jul; 13(3):211-6. PubMed ID: 21063327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of generic medication in epilepsy: a review of potential issues and challenges.
    Van Paesschen W; Hauman H; Lagae L
    Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.
    Kesselheim AS; Stedman MR; Bubrick EJ; Gagne JJ; Misono AS; Lee JL; Brookhart MA; Avorn J; Shrank WH
    Drugs; 2010 Mar; 70(5):605-21. PubMed ID: 20329806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.